Latest Breaking News On - Praxis precision medicines - Page 10 : comparemela.com

Praxis Precision Medicines (NASDAQ:PRAX) Rating Reiterated by HC Wainwright

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They presently have a $105.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 77.54% from the stock’s current price. A number […]

Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response Achieving 100% Response in Treated Patients

Praxis Precision Medicines, Inc. provided an update on its Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. PPR studies measure electroencephalogram signatures after.

Praxis Precision Stock Jumps 26% On Positive Results For Phase 2 Study Of Epilepsy Treatment

Shares of Praxis Precision Medicines, Inc. (PRAX) jumped over 26% on Tuesday morning after the company reported positive results from a phase 2 study of epilepsy treatment.

Jefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its target price boosted by equities researchers at Jefferies Financial Group from $75.00 to $128.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price objective points to a potential upside […]

Top 1% Biotech, Praxis, Releases 'Fireworks' And Catapults To Year-High